Loading organizations...
Loading organizations...
Development of allogeneic cell therapies using CAR-T technology.
Ucello Therapeutics has raised $25.0M across 1 funding round.
Ucello Therapeutics has raised $25.0M in total across 1 funding round.
Ucello Therapeutics has raised $25.0M in total across 1 funding round.
Ucello Therapeutics's investors include Eric Yu, Chengdu Bio-town Fund, Xin Huang, Feng Deng.
Ucello Therapeutics has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series A in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 14, 2022 | $25.0M Series A | Eric Yu | Chengdu Bio-town Fund, Xin Huang, Feng Deng |